Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p
Authors
Keywords
-
Journal
Cancer Medicine
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-06-28
DOI
10.1002/cam4.2350
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Upregulation of microRNA-3129 suppresses epithelial ovarian cancer through CD44
- (2018) Xiaochun Sun et al. CANCER GENE THERAPY
- LncRNA NORAD contributes to colorectal cancer progression by inhibition of miR-202-5p
- (2018) Jie zhang et al. ONCOLOGY RESEARCH
- Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer
- (2018) Huican Huo et al. BIOMEDICINE & PHARMACOTHERAPY
- Long noncoding RNAs: regulation, function and cancer
- (2018) Aras Rafiee et al. Biotechnology & Genetic Engineering Reviews
- Noncoding RNA activated by DNA damage (NORAD): Biologic function and mechanisms in human cancers
- (2018) Zhi Yang et al. CLINICA CHIMICA ACTA
- Ovarian cancer
- (2017) Carlo La Vecchia EUROPEAN JOURNAL OF CANCER PREVENTION
- Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
- (2017) Hongzhe Li et al. Molecular Cancer
- LncRNA-mediated regulation of cell signaling in cancer
- (2017) W-X Peng et al. ONCOGENE
- Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene
- (2016) Junbao Liu et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer Incidence and Survival Trends by Subtype Using Data from the Surveillance Epidemiology and End Results Program, 1992–2013
- (2016) Anne-Michelle Noone et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Long non-coding RNAs as prognostic markers in human breast cancer
- (2016) Hairong Liu et al. Oncotarget
- Characterization of long non-coding RNA-associated ceRNA network to reveal potential prognostic lncRNA biomarkers in human ovarian cancer
- (2016) Meng Zhou et al. Oncotarget
- Mechanisms of regulation of mature miRNAs
- (2015) B. P. Towler et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Long Noncoding RNAs: Cellular Address Codes in Development and Disease
- (2013) Pedro J. Batista et al. CELL
- Long non-coding RNAs: modulators of nuclear structure and function
- (2013) Jan H Bergmann et al. CURRENT OPINION IN CELL BIOLOGY
- MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
- (2013) Wenxing Qin et al. FEBS LETTERS
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data
- (2013) Jun-Hao Li et al. NUCLEIC ACIDS RESEARCH
- Systematic Transcriptome Wide Analysis of lncRNA-miRNA Interactions
- (2013) Saakshi Jalali et al. PLoS One
- Emerging functional and mechanistic paradigms of mammalian long non-coding RNAs
- (2012) V. A. Moran et al. NUCLEIC ACIDS RESEARCH
- starBase: a database for exploring microRNA–mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data
- (2010) Jian-Hua Yang et al. NUCLEIC ACIDS RESEARCH
- Origins and Mechanisms of miRNAs and siRNAs
- (2009) Richard W. Carthew et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More